You do not currently have permission to view the full text for this document. Please sign in to an account with an active subscription or contact support.
The group has celebrated its first anniversary and gave a successful presentation of a paper entitled “A Neuropsychoanalytic Proposal for the Treatment of Borderline Patients Who Use Benzodiazepines” at the NPSA Congress in Athens in June 2012.
Daniela Flores Mosri also presented a poster, “A Neuropsychoanalytic Model of Treatment for Borderline Patients Who Use Cannabis,” which included technical aspects based on case study material, emphasizing the use of nonverbal interventions, as well as metaphorical interpretation, since borderline patients who use cannabis have very specific neurodynamics that reduce their ability to make use of traditional psychoanalytic interpretation. A 10-year-long follow-up has been analyzed with one male patient who shows significant emotional improvement. Other cases have also been taken into account for this proposal.
As a result of the ongoing research projects that the group has been working on, there is a common interest in deepening the study of borderline pathologies since they have become so increasingly common in psychoanalytic practice. Neuropsychoanalytic approaches to this sort of pathology are of great importance to understand the whole functioning of the patient as an integrated human being who needs more finely tailored techniques to relieve suffering.
The study group keeps holding its monthly meetings to discuss specific topics on neuropsychoanalysis.
Daniela Flores Mosri